The Latest Breaking News from Obesity

Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.

Novo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.

Report by Lancet Commission says BMI should be used as ‘screening tool’ rather than determining factor

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of unknowns.

In today’s newsletter: An international commission has called for a ‘radical overhaul’ of the way obesity is diagnosed, raising concerns about the limitations of body mass index (BMI) as a diagnostic tool

It’s the start of another year and the body mass index (BMI) is being criticised again. This time a Lancet-commissioned group of experts is denouncing it as a diagnostic tool for obesity. They say that doctors should look at the overall health of a patient when diagnosing obesity, not just…

Children need portion sizes that reflect their body size

Do people with obesity have an illness? When obesity affects the functions of people's organs, it should be considered a distinct illness called "clinical obesity," the commission said.

Almost a third of parents say they need more guidance on deciding the appropriate portion sizes for their children.